NNE has a two-tier structure: the Board of Directors and NNE Management. The Board of Directors supervise the performance, management and organisation of our company and are elected every year at the Annual General Meeting. They consist of two representatives from our parent company, Novo Nordisk, plus two external members and two employee representatives. NNE Management are responsible for our daily operations and consist of executive management and three country managers.

NNE Management

Jesper Kløve

CEO and President

Jesper Kløve was appointed CEO and President of NNE on 1 September 2015. He comes from Novo Nordisk, where he served as Senior Vice President of Device R&D and was responsible for research and development of the entire medical device portfolio since 2009. He also held various management positions within Novo Nordisk since joining the company in 2003.

René Holmen Pedersen

CFO and Corporate Vice President

René Holmen Pedersen was appointed CFO of NNE on 1 May 2016. Since 2014, René was Director of Business Support at the DFP Site, Tianjin in China. Prior to that, René held various positions at Novo Nordisk since joining in 1998 as a Corporate Business Analyst.

Ole Regnar Hansen

Corporate Vice President and Chief Project Officer

Ole Regnar Hansen was appointed Corporate Vice President and Chief Project Officer in 2015. Prior to this, he served as Corporate Vice President for Project Governance since 2011. He joined NNE in 1999 and has since held several managerial positions in both project and line management. He has been with the Novo Nordisk Group for 29 years.

Michael Topp

President and General Manager, US

Michael Topp is General Manager in 2018 for NNE US. Prior to his appointment, he held positions as Project Director for projects in Asia, Europe, and Americas. He has been with the Novo Group since 2004.

Niels Lynge Agerbaek

Head of West Coast Operations

Niels Lynge Agerbaek was appointed Head of West Coast Operations, US, in November 2018. Niels has over 15 years of experience in GMP and Engineering in the pharmaceutical industry from e.g. Xellia Pharmaceuticals as General Manager (USA) and for Novo Nordisk in both Denmark and China.  Niels holds a master degree in engineering from Aalborg University, a business degree from Copenhagen Business School, and further has a rank as major in the Royal Danish Army.

Sameer Taneja

Corporate Vice President and General Manager, India

Sameer Taneja was appointed Corporate Vice President and General Manager of India in 2015. He has more than 20 years of experience in engineering. Before joining NNE, he served as a department manager for a company specialising in HVAC project execution.

Karsten Munk Knudsen

Chairman of the NNE Board since 2017

Karsten Munk Knudsen, CFO and EVP for Finance, Investor Relations & Procurement, Novo Nordisk A/S. Karsten joined Novo Nordisk in 2003 and has occupied several positions over the years within finance, both in Denmark and in the US. 1999-2003, Karsten headed up Finance in NNIT.

Birgit W. Nørgaard

Vice Chairman of the NNE Board since 2014 and member of the Board since 2011

Birgit Nørgaard has worked as a full-time Board member since 2010. Prior to this, she was CEO of Grontmij | Carl Bro A/S and COO of Grontmij NV, CEO of the Carl Bro Group 2003 – 2006 and CFO 2001 – 2003. Previously, Birgit Nørgaard held executive positions at TDC and Danisco.

Michael Hallgren

Member of the NNE board since 2018

Michael Hallgren is Senior Vice President of Diabetes Active Pharmaceutical Ingredients at Novo Nordisk A/S, which he joined in 1994. In addition to his NNE Board role, Michael is Chairman of Kalundborg Symbiosis and member of the Board of Directors at Novo Nordisk Pharmatech A/S.

Klaus Steen Mortensen

Member of the NNE Board since 2018

Klaus Steen Mortensen is CEO for Bladt Industries A/S, which he joined in 2018. Prior to this Klaus Steen Mortensen held executive positions at Vestas from 2007 – 2018. 

Lis Thodberg

Employee-elected member of the NNE Board since 2018

Lis Thodberg (MSc Biology) is Director for the Health, Safety & Environment department at NNE since 2013. Furthermore she is responsible for driving corporate sustainability management in NNE. 

David Victor Tackie

Employee-elected member of the NNE Board since 2017

David Victor Tackie has been the Manager for the Electrical and Instrumentation department at NNE in Denmark since 2015. He has held a number of management and project management positions both globally and locally.

Corporate governance


NNE A/S is 100% owned by Novo Nordisk A/S and is included in the Consolidated Financial Statements of Novo Nordisk A/S.